Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32


HPV types in cervical cancer tissue in South Africa: A head-to-head comparison by mRNA and DNA tests.

Rad A, Sørbye SW, Dreyer G, Hovland S, Falang BM, Louw M, Skjeldestad FE.

Medicine (Baltimore). 2017 Nov;96(47):e8752. doi: 10.1097/MD.0000000000008752.


Study-based evaluation of the Abbott RealTime High Risk HPV test in comparison to the HC2 HR HPV test in women aged ≥30 years using residual LBC ThinPrep specimens.

Iftner T, Wang L, Iftner A, Holz B, Haedicke-Jarboui J, Iftner N, von Wasielewski R, Martus P, Boehmer G.

BMC Infect Dis. 2016 Nov 11;16(1):672.


Assessment of human papillomavirus E6/E7 oncogene expression as cervical disease biomarker.

Fontecha N, Basaras M, Hernáez S, Andía D, Cisterna R.

BMC Cancer. 2016 Nov 5;16(1):852.


A comparison of different human papillomavirus tests in PreservCyt versus SurePath in a referral population-PREDICTORS 4.

Cuzick J, Ahmad AS, Austin J, Cadman L, Ho L, Terry G, Kleeman M, Ashdown-Barr L, Lyons D, Stoler M, Szarewski A.

J Clin Virol. 2016 Sep;82:145-151. doi: 10.1016/j.jcv.2016.06.015. Epub 2016 Jul 27.


The BD Onclarity HPV Assay on Samples Collected in SurePath Medium Meets the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening.

Ejegod D, Bottari F, Pedersen H, Sandri MT, Bonde J.

J Clin Microbiol. 2016 Sep;54(9):2267-72. doi: 10.1128/JCM.00508-16. Epub 2016 Jun 15.


5-type HPV mRNA versus 14-type HPV DNA test: test performance, over-diagnosis and overtreatment in triage of women with minor cervical lesions.

Westre B, Giske A, Guttormsen H, Sørbye SW, Skjeldestad FE.

BMC Clin Pathol. 2016 Jun 7;16:9. doi: 10.1186/s12907-016-0032-x. eCollection 2016.


Human Papillomavirus Laboratory Testing: the Changing Paradigm.

Burd EM.

Clin Microbiol Rev. 2016 Apr;29(2):291-319. doi: 10.1128/CMR.00013-15. Review.


Cervical Cytology Specimen Stability in Surepath Preservative and Analytical Sensitivity for HPV Testing with the cobas and Hybrid Capture 2 Tests.

Tardif KD, Pyne MT, Malmberg E, Lunt TC, Schlaberg R.

PLoS One. 2016 Feb 23;11(2):e0149611. doi: 10.1371/journal.pone.0149611. eCollection 2016.


Detection of HPV DNA in paraffin-embedded cervical samples: a comparison of four genotyping methods.

Castro FA, Koshiol J, Quint W, Wheeler CM, Gillison ML, Vaughan LM, Kleter B, van Doorn LJ, Chaturvedi AK, Hildesheim A, Schiffman M, Wang SS, Zuna RE, Walker JL, Dunn ST, Wentzensen N.

BMC Infect Dis. 2015 Nov 25;15:544. doi: 10.1186/s12879-015-1281-5.


HPV mRNA is more specific than HPV DNA in triage of women with minor cervical lesions.

Sørbye SW, Fismen S, Gutteberg TJ, Mortensen ES, Skjeldestad FE.

PLoS One. 2014 Nov 18;9(11):e112934. doi: 10.1371/journal.pone.0112934. eCollection 2014.


Comparative evaluation of three commercial systems for detection of high-risk human papillomavirus in cervical and vaginal ThinPrep PreservCyt samples and correlation with biopsy results.

Binnicker MJ, Pritt BS, Duresko BJ, Espy MJ, Grys TE, Zarka MA, Kerr SE, Henry MR.

J Clin Microbiol. 2014 Oct;52(10):3763-8. doi: 10.1128/JCM.01928-14. Epub 2014 Aug 13.


A PCR-based microwell-plate hybrid capture assay for high-risk human papillomavirus.

Wang Y, Liu Y, Ding Y, Sun N, Gong Y, Gao S.

Arch Virol. 2014 Dec;159(12):3365-70. doi: 10.1007/s00705-014-2186-0. Epub 2014 Aug 5.


An intelligent clinical decision support system for patient-specific predictions to improve cervical intraepithelial neoplasia detection.

Bountris P, Haritou M, Pouliakis A, Margari N, Kyrgiou M, Spathis A, Pappas A, Panayiotides I, Paraskevaidis EA, Karakitsos P, Koutsouris DD.

Biomed Res Int. 2014;2014:341483. doi: 10.1155/2014/341483. Epub 2014 Apr 9.


Cancer diagnostic classifiers based on quantitative DNA methylation.

Lorincz AT.

Expert Rev Mol Diagn. 2014 Apr;14(3):293-305. doi: 10.1586/14737159.2014.897610. Review.


Individual detection of 14 high risk human papilloma virus genotypes by the PapType test for the prediction of high grade cervical lesions.

Cuzick J, Ho L, Terry G, Kleeman M, Giddings M, Austin J, Cadman L, Ashdown-Barr L, Costa MJ, Szarewski A.

J Clin Virol. 2014 May;60(1):44-9. doi: 10.1016/j.jcv.2014.02.002. Epub 2014 Feb 14.


A DNA methylation classifier of cervical precancer based on human papillomavirus and human genes.

Brentnall AR, Vasiljević N, Scibior-Bentkowska D, Cadman L, Austin J, Szarewski A, Cuzick J, Lorincz AT.

Int J Cancer. 2014 Sep 15;135(6):1425-32. doi: 10.1002/ijc.28790. Epub 2014 Mar 5.


Credentialing of DNA methylation assays for human genes as diagnostic biomarkers of cervical intraepithelial neoplasia in high-risk HPV positive women.

Vasiljević N, Scibior-Bentkowska D, Brentnall AR, Cuzick J, Lorincz AT.

Gynecol Oncol. 2014 Mar;132(3):709-14. doi: 10.1016/j.ygyno.2014.02.001. Epub 2014 Feb 6.


A comparison of methylation levels in HPV18, HPV31 and HPV33 genomes reveals similar associations with cervical precancers.

Vasiljević N, Scibior-Bentkowska D, Brentnall A, Cuzick J, Lorincz A.

J Clin Virol. 2014 Mar;59(3):161-6. doi: 10.1016/j.jcv.2013.12.014. Epub 2014 Jan 8.

Supplemental Content

Support Center